SCHEMBL5756245

SCHEMBL5756245

CCCCNC(=O)c1cn[nH]c1-c1cc2ccccc2[nH]1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 1/20 0.59
DRD3 P35462 1/20 0.59
TSHR P16473 1/20 0.48
HTT P42858 1/20 0.48
ITK Q08881 1/20 0.48
KDM4E B2RXH2 3/20 0.46
ALDH1A1 P00352 1/20 0.46
RAB9A P51151 1/20 0.45
HSD17B10 Q99714 1/20 0.45
AKR1C3 P42330 1/20 0.44
HPGD P15428 1/20 0.43
HDAC1 Q13547 3/20 0.43
HDAC2 Q92769 3/20 0.43
HDAC3 O15379 2/20 0.43
HDAC4 P56524 2/20 0.43
HDAC7 Q8WUI4 2/20 0.43
HDAC10 Q969S8 2/20 0.43
HDAC11 Q96DB2 2/20 0.43
HDAC8 Q9BY41 2/20 0.43
HDAC6 Q9UBN7 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5759232 0.93 ITK (0.49) DRD2DRD3ITKKDM4EALDH1A1
SCHEMBL5756565 0.89 ITK (0.46) DRD2DRD3ITKKDM4EALDH1A1
SCHEMBL5753974 0.89 HTR2C (0.52) DRD2DRD3HTTITKKDM4E
SCHEMBL5753389 0.83 ITK (0.44) ITKHSD17B10
SCHEMBL5756905 0.83 BRD4 (0.45) TSHRITKKDM4EALDH1A1RAB9A
SCHEMBL5755119 0.82 HSP90AA1 (0.57) ITKKDM4E
SCHEMBL6478111 0.80 ALDH1A1 (0.50) DRD2DRD3TSHRITKKDM4E
SCHEMBL5755157 0.80 DCAF1 (0.45) ITK
SCHEMBL5752698 0.78 HSP90AA1 (0.55) ITKRAB9A
SCHEMBL5755243 0.78 ITK (0.46) TSHRITKKDM4EALDH1A1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1648884-A2 PYRAZOLYL-INDOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM Pharmacia Italia S.p.A. (IT) 2006-04-26 EP disclosed
US-20050032869-A1 Pyrazolyl-indole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them PHARMACIA ITALIA S.P.A. (IT) 2005-02-10 US disclosed
WO-2005005414-A2 PYRAZOLYL-INDOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM PHARMACIA ITALIA S.P.A. (IT) 2005-01-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050032869-A1 Pyrazolyl-indole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them MAP3K9, MAP3K20, MAP3K19 DRD2 3783/4885DRD3 4095/4885TSHR 2449/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.